(Q38006018)

26 August 2017

title

Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics (English)

1 reference

26 August 2017

7

1 reference

26 August 2017

Dimitri P Mikhailidis

8

object named as

Dimitri P Mikhailidis

1 reference

26 August 2017

Charalambos Koumaras

1

1 reference

26 August 2017

Maria Tzimou

2

1 reference

26 August 2017

Eirini Stavrinou

3

1 reference

26 August 2017

Theodora Griva

4

1 reference

26 August 2017

Thomas D Gossios

5

1 reference

26 August 2017

Niki Katsiki

6

1 reference

26 August 2017

Asterios Karagiannis

9

1 reference

26 August 2017

publication date

1 June 2012

1 reference

American journal of cardiovascular drugs

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

143-156

1 reference

Expert consensus document on arterial stiffness: methodological issues and clinical applications

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Endothelial function, arterial stiffness and lipid lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Aging and arterial stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Gender differences in artery wall biomechanical properties throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Age, hypertension and arterial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Obesity and arterial compliance alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

The effect of smoking on arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Central blood pressure measurements and antihypertensive therapy: a consensus document

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Aortic stiffness is an independent predictor of fatal stroke in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial stiffness and cardiovascular events: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of different antihypertensive drug classes on central aortic pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

A comparison of atenolol and nebivolol in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Early vascular benefits of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Ambulatory arterial stiffness index: rationale and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Pulse pressure, arterial stiffness, and drug treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Antihypertensive therapy and de-stiffening of the arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial stiffness and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial stiffness, endothelial function and novel pharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Can antihypertensive treatment reverse large-artery stiffening?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Selective reduction of central pulse pressure under angiotensin blockage in SHR: role of the fibronectin-alpha5beta1 integrin complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Aldosterone-induced cardiac damage: focus on blood pressure independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Nitrate tolerance: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Nebivolol increases arterial distensibility in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial stiffness, hypertension, and rational use of nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Irbesartan improves arterial compliance more than lisinopril

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Comparison of the effects of diuretics on blood pressure and arterial stiffness in patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Radial arterial pressure measurements may be a poor guide to the beneficial effects of nitroprusside on left ventricular systolic pressure in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599040-000000000-00000

10.2165/11599040-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1005716402

0 references

1 reference